SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis

Journal of Molecular Medicine

Volumn 84, Issue 2, 2006, Pages 175-182

  Ruchusatsawat, Kriangsak ^a,b   Wongpiyabovorn, Jongkonnee ^a   Shuangshoti, Shanop ^a   Hirankarn, Nattiya ^a   Mutirangura, Apiwat ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Demethylation; DNA Methylation; Psoriasis; PTPN6; SHP 1

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE SHP 1;

ARTICLE; BLADDER EPITHELIUM; BREAST EPITHELIUM; DEMETHYLATION; DNA METHYLATION; EPITHELIUM; EPITHELIUM CELL; GENETIC TRANSCRIPTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; KIDNEY EPITHELIUM; LEUKOCYTE; LIVER CELL; LUNG ALVEOLUS EPITHELIUM; MICRODISSECTION; PROMOTER REGION; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PSORIASIS; SKIN DISEASE; SKIN EPITHELIUM; TRANSCRIPTION REGULATION; UTERINE CERVIX EPITHELIUM;

CELL LINE; DNA METHYLATION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; PSORIASIS; SHP1 PROTEIN TYROSINE PHOSPHATASE;

EID: 32044433285     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-005-0020-6     Document Type: Article

References (37)

1. Bruecher-Encke B, Griffin JD, Neel BG, Lorenz U (2001) Role of the tyrosine phosphatase SHP-1 in K562 cell differentiation. Leukemia 15:1424-1432
2. Zapata PD, Ropero RM, Valencia AM et al (2002) Autocrine regulation of human prostate carcinoma cell proliferation by somatostatin through the modulation of the SH2 domain containing protein tyrosine phosphatase (SHP)-1. J Clin Endocrinol Metab 87:915-926
3. Zhang Q, Raghunath PN, Vonderheid E, Odum N, Wasik MA (2000) Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter. Am J Pathol 157:1137-1146
4. Oka T, Yoshino T, Hayashi K et al (2001) Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias: combination analysis with cDNA expression array and tissue microarray. Am J Pathol 159:1495-1505
5. Ching TT, Maunakea AK, Jun P et al (2005) Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3. Nat Genet 37:645-651
6. Song F, Smith JF, Kimura MT et al (2005) Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc Natl Acad Sci U S A 102:3336-3341
7. Yip SS, Crew AJ, Gee JM et al (2000) Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expression. Int J Cancer 88:363-368
8. Mok SC, Kwok TT, Berkowitz RS, Barrett AJ, Tsui FW (1995) Overexpression of the protein tyrosine phosphatase, nonreceptor type 6 (PTPN6), in human epithelial ovarian cancer. Gynecol Oncol 57:299-303
9. Wu C, Sun M, Liu L, Zhou GW (2003) The function of the protein tyrosine phosphatase SHP-1 in cancer. Gene 306:1-12
10. Yi TL, Cleveland JL, Dile JN (1992) Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol Cell Biol 12:836-846
11. Banville D, Stocco R, Shen SH (1995) Human protein tyrosine phosphatase 1C (PTPN6) gene structure: alternate promoter usage and exon skipping generate multiple transcripts. Genomics 27:165-173
12. Zhang Q, Wang HY, Marzec M, Raghunath PN, Nagasawa T, Wasik MA (2005) STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci U S A 102:6948-6953
13. Sano S, Chan KS, Carbajal S et al (2005) Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11:43-49
14. Chaturvedi V, Qin JZ, Denning MF, Choubey D, Diaz MO, Nickoloff BJ (1999) Apoptosis in proliferating, senescent, and immortalized keratinocytes. J Biol Chem 274:23358-23367
15. Nickoloff BJ, Nestle FO (2004) Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 113:1664-1675
16. Green MR (2004) Targeting targeted therapy. N Engl J Med 350:2191-2193
17. Chalitchagorn K, Shuangshoti S, Hourpai N et al (2004) Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23:8841-8846
18. Mutirangura A, Charuruks N, Shuangshoti S et al (1999) Identification of distinct regions of allelic loss on chromosome 13q in nasopharyngeal cancer from paraffin embedded tissues. Int J Cancer 83:210-214
19. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93:9821-9826
20. Koyama M, Oka T, Ouchida M et al (2003) Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation. Lab Invest 83:1849-1858
21. Xiong Z, Laird PW (1997) COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25:2532-2534
22. Wongpiyabovorn J, Suto H, Ushio H et al (2003) Up-regulation of interleukin-13 receptor alpha1 on human keratinocytes in the skin of psoriasis and atopic dermatitis. J Dermatol Sci 33:31-40
23. Bird AP, Wolffe AP (1999) Methylation-induced repression-belts, braces, and chromatin. Cell 99:451-454
24. Jones PA, Takai D (2001) The role of DNA methylation in mammalian epigenetics. Science 293:1068-1070
25. Reik W, Dean W, Walter J (2001) Epigenetic reprogramming in mammalian development. Science 293:1089-1093
26. Shiota K, Kogo Y, Ohgane J et al (2002) Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice. Genes Cells 7:961-969
27. Feinberg AP (2004) The epigenetics of cancer etiology. Semin Cancer Biol 14:427-432
28. Das PM, Singal R (2004) DNA methylation and cancer. J Clin Oncol 22:4632-4642
29. He B, You L, Uematsu K et al (2003) SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci U S A 100:14133-14138
30. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP (2000) Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25:315-319
31. Lorenz U, Bergemann AD, Steinberg HN et al (1996) Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1. J Exp Med 184:1111-1126
32. Paulson RF, Vesely S, Siminovitch KA, Bernstein A (1996) Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nat Genet 13:309-315
33. Paling NR, Welham MJ (2002) Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling. Biochem J 368:885-894
34. Minoo P, Zadeh MM, Rottapel R, Lebrun JJ, Ali S (2004) A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling. Blood 103:1398-1407
35. Chen HE, Chang S, Trub T, Neel BG (1996) Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 16:3685-3697
36. Wrone-Smith T, Nickoloff BJ (1996) Dermal injection of immunocytes induces psoriasis. J Clin Invest 98:1878-1887
37. McKenzie RC, Sabin E (2003) Aberrant signalling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis. Exp Dermatol 12:337-345